{"id":27635,"date":"2025-07-08T17:01:27","date_gmt":"2025-07-09T00:01:27","guid":{"rendered":"https:\/\/ameripharmaspecialty.com\/?p=27635"},"modified":"2026-04-24T13:44:17","modified_gmt":"2026-04-24T20:44:17","slug":"odomzo-a-targeted-oral-medication-for-basal-cell-carcinoma","status":"publish","type":"post","link":"https:\/\/ameripharmaspecialty.com\/es\/cancer\/odomzo-a-targeted-oral-medication-for-basal-cell-carcinoma\/","title":{"rendered":"Odomzo: Un medicamento oral espec\u00edfico para el carcinoma basocelular"},"content":{"rendered":"<p>Odomzo (sonidegib) es un medicamento que trata el carcinoma basocelular (CCB), un tipo de c\u00e1ncer de piel que se desarrolla en la capa m\u00e1s superficial de la piel. Es un tipo com\u00fan de c\u00e1ncer de piel que afecta a aproximadamente... <a href=\"https:\/\/www.skincancer.org\/skin-cancer-information\/basal-cell-carcinoma\/\">3,6 millones de estadounidenses<\/a> Cada a\u00f1o.&nbsp;<\/p>\n\n\n\n<div  id=\"call-to-action-e9dc49fd00c28fd234ad2b14097652a1\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tObtenga asistencia financiera\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"#form\">Empezar<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<p>Aunque muchos casos se tratan f\u00e1cilmente con cirug\u00eda o radioterapia, algunos se vuelven m\u00e1s complejos, ya sea porque reaparecen despu\u00e9s del tratamiento o porque crecen de forma que las terapias est\u00e1ndar son menos efectivas. Para estos casos complejos, los m\u00e9dicos prescriben tratamientos m\u00e1s avanzados, como Odomzo (sonidegib).&nbsp;<\/p>\n\n\n\n<p>Odomzo es un medicamento oral dirigido dise\u00f1ado para <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC4849341\/\">tratar el carcinoma basocelular localmente avanzado (laBBC)<\/a> cuando la cirug\u00eda o la radioterapia ya no son una opci\u00f3n. Este art\u00edculo explica c\u00f3mo funciona Odomzo, qui\u00e9nes pueden usarlo y qu\u00e9 deben saber los pacientes sobre este medicamento.<\/p>\n\n\n\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_83 counter-hierarchy ez-toc-counter ez-toc-custom ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Alternar tabla de contenido\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Palanca<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewbox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewbox=\"0 0 24 24\" version=\"1.2\" baseprofile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/odomzo-a-targeted-oral-medication-for-basal-cell-carcinoma\/#Odomzo_Usage_or_Indication\" >Odomzo: Uso o indicaci\u00f3n<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/odomzo-a-targeted-oral-medication-for-basal-cell-carcinoma\/#Odomzo_Mode_of_Action\" >Odomzo: Modo de acci\u00f3n<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/odomzo-a-targeted-oral-medication-for-basal-cell-carcinoma\/#Dosage_and_Administration\" >Dosis y administraci\u00f3n<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/odomzo-a-targeted-oral-medication-for-basal-cell-carcinoma\/#Common_Side_Effects\" >Efectos secundarios comunes<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/odomzo-a-targeted-oral-medication-for-basal-cell-carcinoma\/#Contraindications_Who_Should_Not_Take_Odomzo\" >Contraindicaciones (Qui\u00e9n no debe tomar Odomzo)<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/odomzo-a-targeted-oral-medication-for-basal-cell-carcinoma\/#Before_You_Start_Odomzo_What_To_Tell_Your_Doctor\" >Antes de empezar a tomar Odomzo: Qu\u00e9 decirle a su m\u00e9dico<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/odomzo-a-targeted-oral-medication-for-basal-cell-carcinoma\/#During_Treatment_What_To_Avoid_While_Taking_Odomzo\" >Durante el tratamiento: Qu\u00e9 evitar al tomar Odomzo<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/odomzo-a-targeted-oral-medication-for-basal-cell-carcinoma\/#Blood_or_Sperm_Donations\" >Donaciones de sangre o esperma<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/odomzo-a-targeted-oral-medication-for-basal-cell-carcinoma\/#Certain_Medications\" >Ciertos medicamentos<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/odomzo-a-targeted-oral-medication-for-basal-cell-carcinoma\/#Grapefruit_and_Grapefruit_Juice\" >Toronja y jugo de toronja<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/odomzo-a-targeted-oral-medication-for-basal-cell-carcinoma\/#Strenuous_Physical_Activity\" >Actividad f\u00edsica intensa<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/odomzo-a-targeted-oral-medication-for-basal-cell-carcinoma\/#Cost\" >Costo<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/odomzo-a-targeted-oral-medication-for-basal-cell-carcinoma\/#Frequently_Asked_Questions_FAQs\" >Preguntas frecuentes (FAQ)<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\" id=\"h-odomzo-usage-or-indication\"><span class=\"ez-toc-section\" id=\"Odomzo_Usage_or_Indication\"><\/span><strong>Odomzo: Uso o indicaci\u00f3n<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>El Odomzo est\u00e1 aprobado por la FDA y solo est\u00e1 indicado para el tratamiento del carcinoma basocelular (CBC) localmente avanzado en pacientes adultos. Este medicamento tambi\u00e9n se prescribe a pacientes cuyo c\u00e1ncer ha reaparecido tras una cirug\u00eda o a quienes no pueden someterse a cirug\u00eda o radioterapia para extirpar completamente el c\u00e1ncer.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-odomzo-mode-of-action\"><span class=\"ez-toc-section\" id=\"Odomzo_Mode_of_Action\"><\/span><strong>Odomzo: Modo de acci\u00f3n<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>El carcinoma basocelular (CBC) se produce como resultado del crecimiento descontrolado de las c\u00e9lulas basales debido a la hiperactividad de la v\u00eda de se\u00f1alizaci\u00f3n Hedgehog. Esta v\u00eda molecular controla normalmente el crecimiento y la reparaci\u00f3n celular en la piel.&nbsp;<\/p>\n\n\n\n<p>Sonidegib, el principio activo de Odomzo, es un inhibidor de la v\u00eda Hedgehog <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC4849341\/\">inhibidor que se une a una prote\u00edna alisada (SMO)<\/a>Esta prote\u00edna controla principalmente la v\u00eda de se\u00f1alizaci\u00f3n de Hedgehog y, al bloquearla, sonidegib... <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC4849341\/\">apaga la se\u00f1alizaci\u00f3n anormal<\/a> que impulsa el crecimiento de las c\u00e9lulas cancerosas.&nbsp;<\/p>\n\n\n\n<p>Al trabajar de esta manera, Odomzo podr\u00eda ayudar a reducir el tama\u00f1o del tumor.<strong>.&nbsp;<\/strong><\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-dosage-and-administration\"><span class=\"ez-toc-section\" id=\"Dosage_and_Administration\"><\/span><strong>Dosis y administraci\u00f3n<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Odomzo est\u00e1 disponible en c\u00e1psulas de 200 mg. La dosis recomendada para adultos con carcinoma basocelular (CCB) es una c\u00e1psula oral una vez al d\u00eda. Tome las c\u00e1psulas de Odomzo con el est\u00f3mago vac\u00edo, al menos una hora antes o dos horas despu\u00e9s de comer.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-common-side-effects\"><span class=\"ez-toc-section\" id=\"Common_Side_Effects\"><\/span><strong>Efectos secundarios comunes<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>El m\u00e1s com\u00fan <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7211768\/\">Efectos secundarios notificados por \u226510% de los pacientes<\/a> incluir:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>espasmos musculares&nbsp;<\/li>\n\n\n\n<li>P\u00e9rdida de cabello (alopecia)<\/li>\n\n\n\n<li>Alteraci\u00f3n del gusto (disgeusia)<\/li>\n\n\n\n<li>Cansancio<\/li>\n\n\n\n<li>N\u00e1useas y v\u00f3mitos<\/li>\n\n\n\n<li>Dolores musculares y musculares (mialgia)<\/li>\n\n\n\n<li>Dolor en una articulaci\u00f3n (artralgia)<\/li>\n\n\n\n<li>Dolor abdominal<\/li>\n\n\n\n<li>Dolor de cabeza<\/li>\n\n\n\n<li>Diarrea<\/li>\n\n\n\n<li>P\u00e9rdida de peso<\/li>\n\n\n\n<li>P\u00e9rdida de apetito<\/li>\n\n\n\n<li>Picaz\u00f3n (prurito)<\/li>\n\n\n\n<li>Orinar poco o nada<\/li>\n\n\n\n<li>orina de color oscuro<\/li>\n\n\n\n<li>Fatiga y dolor<\/li>\n<\/ul>\n\n\n\n<p>En mujeres f\u00e9rtiles, el Odomzo puede causar ausencia de menstruaci\u00f3n (amenorrea). Se desconoce si la amenorrea es permanente.&nbsp;<\/p>\n\n\n\n<p>Contacte a su profesional de la salud si experimenta alguno de los s\u00edntomas mencionados despu\u00e9s de tomar Odomzo. Su m\u00e9dico podr\u00eda recetarle medicamentos para controlar ciertos efectos secundarios, como n\u00e1useas o v\u00f3mitos.<\/p>\n\n\n\n<p>En algunos casos, si los calambres o la debilidad muscular son graves, su proveedor de atenci\u00f3n m\u00e9dica puede cambiar su dosis o suspender su tratamiento temporal o permanentemente.&nbsp;<\/p>\n\n\n\n<div  id=\"call-to-action-2255583e5ef36a761e154919cfae9e32\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tObtenga asistencia con el copago ahora\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"tel:8777780318\">(877) 778-0318<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-contraindications-who-should-not-take-odomzo\"><span class=\"ez-toc-section\" id=\"Contraindications_Who_Should_Not_Take_Odomzo\"><\/span><strong>Contraindicaciones (Qui\u00e9n no debe tomar Odomzo)<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"alignright size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"420\" height=\"280\" src=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/doctor-patient.jpg\" alt=\"Patient on Odomzo meeting with physician and discussing contraindications\" class=\"wp-image-27637\" srcset=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/doctor-patient.jpg 420w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/doctor-patient-300x200.jpg 300w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/doctor-patient-18x12.jpg 18w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/doctor-patient-330x220.jpg 330w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/doctor-patient-86x57.jpg 86w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/doctor-patient-167x111.jpg 167w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/doctor-patient-280x187.jpg 280w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/doctor-patient-370x247.jpg 370w\" sizes=\"auto, (max-width: 420px) 100vw, 420px\" \/><\/figure>\n<\/div>\n\n\n<p>El Odomzo puede causar defectos cong\u00e9nitos graves o muerte fetal. Est\u00e1 estrictamente contraindicado.<em> <\/em>En mujeres embarazadas. Las mujeres en edad f\u00e9rtil deben presentar una prueba de embarazo negativa antes de iniciar el tratamiento y utilizar un m\u00e9todo anticonceptivo eficaz durante el tratamiento y hasta 20 meses despu\u00e9s de la \u00faltima dosis.<\/p>\n\n\n\n<p>Hombres<strong> <\/strong>Debe usar condones durante el tratamiento y para<strong> <\/strong>8 meses despu\u00e9s de la \u00faltima dosis, ya que el medicamento puede estar presente en el semen.<\/p>\n\n\n\n<p>Los pacientes con alergia conocida al sonidegib o a cualquiera de sus componentes no deben tomar Odomzo.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-before-you-start-odomzo-what-to-tell-your-doctor\"><span class=\"ez-toc-section\" id=\"Before_You_Start_Odomzo_What_To_Tell_Your_Doctor\"><\/span><strong>Antes de empezar a tomar Odomzo: Qu\u00e9 decirle a su m\u00e9dico<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Siempre consulte a su proveedor de atenci\u00f3n m\u00e9dica antes de tomar Odomzo si:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Tiene dolor o espasmos musculares, o tiene antecedentes de un trastorno muscular llamado rabdomi\u00f3lisis o miopat\u00eda.<\/li>\n\n\n\n<li>Tiene alguna otra condici\u00f3n m\u00e9dica, como enfermedad renal.<\/li>\n\n\n\n<li>Est\u00e1 embarazada o planea quedar embarazada (Odomzo puede causar muerte embriofetal o defectos cong\u00e9nitos graves)<\/li>\n\n\n\n<li>Est\u00e1 amamantando o planea amamantar (Dado que no se sabe si Odomzo pasa a la leche materna,<strong> <\/strong>Se debe evitar la lactancia materna durante el tratamiento y hasta 20 meses despu\u00e9s de la \u00faltima dosis.<strong>).<\/strong><\/li>\n\n\n\n<li>Tomar cualquier medicamento con o sin receta, como medicamentos de venta libre, suplementos o productos a base de hierbas.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-during-treatment-what-to-avoid-while-taking-odomzo\"><span class=\"ez-toc-section\" id=\"During_Treatment_What_To_Avoid_While_Taking_Odomzo\"><\/span><strong>Durante el tratamiento: Qu\u00e9 evitar al tomar Odomzo<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Mientras est\u00e9 tomando Odomzo, es importante evitar:<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-blood-or-sperm-donations\"><span class=\"ez-toc-section\" id=\"Blood_or_Sperm_Donations\"><\/span><strong>Donaciones de sangre o esperma<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Se recomienda no donar sangre durante el tratamiento ni durante al menos 20 meses despu\u00e9s de la \u00faltima dosis. Asimismo, los hombres deben evitar donar semen durante el tratamiento y durante los 8 meses posteriores.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-certain-medications\"><span class=\"ez-toc-section\" id=\"Certain_Medications\"><\/span><strong>Ciertos medicamentos<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Evite los inhibidores o inductores potentes y moderados del CYP3A (p. ej., ketoconazol, rifampicina, fenito\u00edna), ya que pueden afectar la acci\u00f3n de Odomzo o aumentar los efectos secundarios. Informe siempre a su m\u00e9dico sobre todos los medicamentos y suplementos que est\u00e9 tomando.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-grapefruit-and-grapefruit-juice\"><span class=\"ez-toc-section\" id=\"Grapefruit_and_Grapefruit_Juice\"><\/span><strong>Toronja y jugo de toronja<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Evite consumir productos de pomelo, ya que pueden interferir con la forma en que se metaboliza el Odomzo en el cuerpo.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-strenuous-physical-activity\"><span class=\"ez-toc-section\" id=\"Strenuous_Physical_Activity\"><\/span><strong>Actividad f\u00edsica intensa<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Evite hacer ejercicio o haga ejercicio con precauci\u00f3n, ya que Odomzo puede causar dolor o debilidad muscular.<strong>.<\/strong> Informe a su m\u00e9dico si siente calambres musculares, dolores o fatiga inusual.<\/p>\n\n\n\n<div  id=\"call-to-action-317107ec55cf6aa71b473ebae29074e3\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tHabla con un especialista\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"cta__sub__heading\">\n\t\t\t\t\t\t\tAcerca de la asistencia para copagos\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"#form\">M\u00e1s informaci\u00f3n<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-cost\"><span class=\"ez-toc-section\" id=\"Cost\"><\/span><strong>Costo<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Odomzo (c\u00e1psula oral de 200 mg) es un medicamento caro, y costar\u00e1 aproximadamente $15,262 por un suministro de 30 c\u00e1psulas sin un plan de seguro. Sin embargo, dentro de los planes de seguro, los programas de copago del fabricante<strong>, <\/strong>Si usted cuenta con el apoyo de fundaciones de asistencia al paciente, puede obtener este medicamento a bajo costo o incluso gratis si cumple con los requisitos. <a href=\"https:\/\/ameripharmaspecialty.com\/es\/financial-assistance\/\">Cont\u00e1ctanos<\/a> si est\u00e1 interesado en explorar opciones de asistencia financiera o <a href=\"https:\/\/ameripharmaspecialty.com\/es\/odomzo-copay-assistance\/\">Asistencia para el copago del art\u00edculo Odomzo<\/a>.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-frequently-asked-questions-faqs\"><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions_FAQs\"><\/span><strong>Preguntas frecuentes (FAQ)<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-is-odomzo-chemotherapy\"><strong>\u00bfOdomzo es quimioterapia?<\/strong><\/h4>\n\n\n\n<p>Odomzo no es quimioterapia. Es un medicamento oral aprobado por la FDA en 2015 para el tratamiento del carcinoma basocelular (CBC) localmente avanzado en pacientes adultos cuyo c\u00e1ncer ha recurrido tras el tratamiento est\u00e1ndar.&nbsp;<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-does-odomzo-work-differently-from-chemotherapy\"><strong>\u00bfEl Odomzo funciona de forma diferente a la quimioterapia?<\/strong><\/h4>\n\n\n\n<p>El Odomzo funciona de forma diferente a la quimioterapia, ya que bloquea la v\u00eda molecular para detener el crecimiento de las c\u00e9lulas cancerosas. Tiene la capacidad de penetrar m\u00e1s profundamente en el tejido y atacar el tumor donde reside.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-what-if-i-forget-to-take-a-pill\"><strong>\u00bfQu\u00e9 pasa si me olvido de tomar una pastilla?<\/strong><\/h4>\n\n\n\n<p>Si olvida una dosis, s\u00e1ltela. Tome la siguiente dosis seg\u00fan lo programado. No tome dos dosis para compensar la dosis olvidada.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-what-are-the-most-serious-side-effects\"><strong>\u00bfCu\u00e1les son los efectos secundarios m\u00e1s graves?<\/strong><\/h4>\n\n\n\n<p>El gen Odomzo puede causar muerte fetal o defectos cong\u00e9nitos graves. Com\u00fanmente causa dolor o espasmos musculares, que a veces pueden indicar problemas musculares graves, incluyendo casos raros de... <a href=\"https:\/\/my.clevelandclinic.org\/health\/diseases\/21184-rhabdomyolysis\">rabdomi\u00f3lisis<\/a> que pueden provocar da\u00f1o renal.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-what-if-i-can-t-tolerate-the-side-effects\"><strong>\u00bfQu\u00e9 pasa si no tolero los efectos secundarios?<\/strong><\/h4>\n\n\n\n<p>Hable con su m\u00e9dico sobre cualquier efecto secundario que experimente. Inf\u00f3rmele de inmediato si le molestan o no desaparecen.<\/p>","protected":false},"excerpt":{"rendered":"<p>Odomzo (sonidegib) es un medicamento que trata el carcinoma basocelular (CCB), un tipo de c\u00e1ncer de piel que se desarrolla en la capa superficial de la piel. Es un tipo com\u00fan de c\u00e1ncer de piel que afecta a aproximadamente 3,6 millones de estadounidenses cada a\u00f1o.\u00a0<\/p>","protected":false},"author":13,"featured_media":27636,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"om_disable_all_campaigns":false,"_uag_custom_page_level_css":"","footnotes":""},"categories":[13],"tags":[17],"class_list":["post-27635","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-cancer","tag-dr-saba-rassouli"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Odomzo: A Targeted Oral Medication for Basal Cell Carcinoma - AmeriPharma\u00ae Specialty Care<\/title>\n<meta name=\"description\" content=\"Learn about how Odomzo can help treat basal cell carcinoma. Topics include mode of action, side effects, dosage, and more.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/odomzo-a-targeted-oral-medication-for-basal-cell-carcinoma\/\" \/>\n<meta property=\"og:locale\" content=\"es_MX\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Odomzo: A Targeted Oral Medication for Basal Cell Carcinoma - AmeriPharma\u00ae Specialty Care\" \/>\n<meta property=\"og:description\" content=\"Learn about how Odomzo can help treat basal cell carcinoma. Topics include mode of action, side effects, dosage, and more.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/odomzo-a-targeted-oral-medication-for-basal-cell-carcinoma\/\" \/>\n<meta property=\"og:site_name\" content=\"AmeriPharma\u00ae Specialty Care\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ameripharma\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-07-09T00:01:27+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-24T20:44:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/doctor-skin-exam.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"854\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Dr. Saba Rassouli, PharmD\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Dr. Saba Rassouli, PharmD\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/cancer\\\/odomzo-a-targeted-oral-medication-for-basal-cell-carcinoma\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/cancer\\\/odomzo-a-targeted-oral-medication-for-basal-cell-carcinoma\\\/\"},\"author\":{\"name\":\"Dr. Saba Rassouli, PharmD\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#\\\/schema\\\/person\\\/f70b3467e035aab4ae14bdadd64c5c01\"},\"headline\":\"Odomzo: A Targeted Oral Medication for Basal Cell Carcinoma\",\"datePublished\":\"2025-07-09T00:01:27+00:00\",\"dateModified\":\"2026-04-24T20:44:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/cancer\\\/odomzo-a-targeted-oral-medication-for-basal-cell-carcinoma\\\/\"},\"wordCount\":1056,\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/cancer\\\/odomzo-a-targeted-oral-medication-for-basal-cell-carcinoma\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/doctor-skin-exam.jpg\",\"keywords\":[\"Dr. Saba Rassouli\"],\"articleSection\":[\"Cancer\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/cancer\\\/odomzo-a-targeted-oral-medication-for-basal-cell-carcinoma\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/cancer\\\/odomzo-a-targeted-oral-medication-for-basal-cell-carcinoma\\\/\",\"name\":\"Odomzo: A Targeted Oral Medication for Basal Cell Carcinoma - AmeriPharma\u00ae Specialty Care\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/cancer\\\/odomzo-a-targeted-oral-medication-for-basal-cell-carcinoma\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/cancer\\\/odomzo-a-targeted-oral-medication-for-basal-cell-carcinoma\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/doctor-skin-exam.jpg\",\"datePublished\":\"2025-07-09T00:01:27+00:00\",\"dateModified\":\"2026-04-24T20:44:17+00:00\",\"description\":\"Learn about how Odomzo can help treat basal cell carcinoma. Topics include mode of action, side effects, dosage, and more.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/cancer\\\/odomzo-a-targeted-oral-medication-for-basal-cell-carcinoma\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/cancer\\\/odomzo-a-targeted-oral-medication-for-basal-cell-carcinoma\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/cancer\\\/odomzo-a-targeted-oral-medication-for-basal-cell-carcinoma\\\/#primaryimage\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/doctor-skin-exam.jpg\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/doctor-skin-exam.jpg\",\"width\":1280,\"height\":854,\"caption\":\"Doctor examining skin of patient who has basal cell carcinoma\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/cancer\\\/odomzo-a-targeted-oral-medication-for-basal-cell-carcinoma\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Odomzo: A Targeted Oral Medication for Basal Cell Carcinoma\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/\",\"name\":\"AmeriPharma\u00ae Specialty Care\",\"description\":\"Specialty Care by AmeriPharma\",\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#organization\",\"name\":\"Ameripharma Specialty Care\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"width\":400,\"height\":400,\"caption\":\"Ameripharma Specialty Care\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/ameripharma\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#\\\/schema\\\/person\\\/f70b3467e035aab4ae14bdadd64c5c01\",\"name\":\"Dr. Saba Rassouli, PharmD\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a5087340dca0d3046e3ff88f5dfa11d515d21ea9e06e6aec23e56d7fddfee7ce?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a5087340dca0d3046e3ff88f5dfa11d515d21ea9e06e6aec23e56d7fddfee7ce?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a5087340dca0d3046e3ff88f5dfa11d515d21ea9e06e6aec23e56d7fddfee7ce?s=96&d=mm&r=g\",\"caption\":\"Dr. Saba Rassouli, PharmD\"},\"description\":\"Dr. Saba Rassouli, PharmD was born and raised in Iran. She received her pharmacy degree from Marshall B. Ketchum University in 2022, where she graduated cum laude. The most rewarding part of her job is having the opportunity to care for each patient as if they were family and hearing about how happy and satisfied they are with the services provided by AmeriPharma. In her free time, she likes to go on walks, read books, and try different restaurants and foods.\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/author\\\/saba-rassouli\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Odomzo: Un medicamento oral espec\u00edfico para el carcinoma basocelular - AmeriPharma\u00ae Atenci\u00f3n especializada","description":"Aprenda c\u00f3mo el Odomzo puede ayudar a tratar el carcinoma basocelular. Los temas incluyen el mecanismo de acci\u00f3n, los efectos secundarios, la dosis y m\u00e1s.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ameripharmaspecialty.com\/es\/cancer\/odomzo-a-targeted-oral-medication-for-basal-cell-carcinoma\/","og_locale":"es_MX","og_type":"article","og_title":"Odomzo: A Targeted Oral Medication for Basal Cell Carcinoma - AmeriPharma\u00ae Specialty Care","og_description":"Learn about how Odomzo can help treat basal cell carcinoma. Topics include mode of action, side effects, dosage, and more.","og_url":"https:\/\/ameripharmaspecialty.com\/es\/cancer\/odomzo-a-targeted-oral-medication-for-basal-cell-carcinoma\/","og_site_name":"AmeriPharma\u00ae Specialty Care","article_publisher":"https:\/\/www.facebook.com\/ameripharma\/","article_published_time":"2025-07-09T00:01:27+00:00","article_modified_time":"2026-04-24T20:44:17+00:00","og_image":[{"width":1280,"height":854,"url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/doctor-skin-exam.jpg","type":"image\/jpeg"}],"author":"Dr. Saba Rassouli, PharmD","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Dr. Saba Rassouli, PharmD","Est. reading time":"5 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ameripharmaspecialty.com\/es\/cancer\/odomzo-a-targeted-oral-medication-for-basal-cell-carcinoma\/#article","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/cancer\/odomzo-a-targeted-oral-medication-for-basal-cell-carcinoma\/"},"author":{"name":"Dr. Saba Rassouli, PharmD","@id":"https:\/\/ameripharmaspecialty.com\/es\/#\/schema\/person\/f70b3467e035aab4ae14bdadd64c5c01"},"headline":"Odomzo: A Targeted Oral Medication for Basal Cell Carcinoma","datePublished":"2025-07-09T00:01:27+00:00","dateModified":"2026-04-24T20:44:17+00:00","mainEntityOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/cancer\/odomzo-a-targeted-oral-medication-for-basal-cell-carcinoma\/"},"wordCount":1056,"publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/#organization"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/cancer\/odomzo-a-targeted-oral-medication-for-basal-cell-carcinoma\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/doctor-skin-exam.jpg","keywords":["Dr. Saba Rassouli"],"articleSection":["Cancer"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/ameripharmaspecialty.com\/es\/cancer\/odomzo-a-targeted-oral-medication-for-basal-cell-carcinoma\/","url":"https:\/\/ameripharmaspecialty.com\/es\/cancer\/odomzo-a-targeted-oral-medication-for-basal-cell-carcinoma\/","name":"Odomzo: Un medicamento oral espec\u00edfico para el carcinoma basocelular - AmeriPharma\u00ae Atenci\u00f3n especializada","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/cancer\/odomzo-a-targeted-oral-medication-for-basal-cell-carcinoma\/#primaryimage"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/cancer\/odomzo-a-targeted-oral-medication-for-basal-cell-carcinoma\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/doctor-skin-exam.jpg","datePublished":"2025-07-09T00:01:27+00:00","dateModified":"2026-04-24T20:44:17+00:00","description":"Aprenda c\u00f3mo el Odomzo puede ayudar a tratar el carcinoma basocelular. Los temas incluyen el mecanismo de acci\u00f3n, los efectos secundarios, la dosis y m\u00e1s.","breadcrumb":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/cancer\/odomzo-a-targeted-oral-medication-for-basal-cell-carcinoma\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ameripharmaspecialty.com\/es\/cancer\/odomzo-a-targeted-oral-medication-for-basal-cell-carcinoma\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/ameripharmaspecialty.com\/es\/cancer\/odomzo-a-targeted-oral-medication-for-basal-cell-carcinoma\/#primaryimage","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/doctor-skin-exam.jpg","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/doctor-skin-exam.jpg","width":1280,"height":854,"caption":"Doctor examining skin of patient who has basal cell carcinoma"},{"@type":"BreadcrumbList","@id":"https:\/\/ameripharmaspecialty.com\/es\/cancer\/odomzo-a-targeted-oral-medication-for-basal-cell-carcinoma\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ameripharmaspecialty.com\/"},{"@type":"ListItem","position":2,"name":"Odomzo: A Targeted Oral Medication for Basal Cell Carcinoma"}]},{"@type":"WebSite","@id":"https:\/\/ameripharmaspecialty.com\/es\/#website","url":"https:\/\/ameripharmaspecialty.com\/es\/","name":"Cuidado especializado AmeriPharma\u00ae","description":"Atenci\u00f3n especializada por AmeriPharma","publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ameripharmaspecialty.com\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/ameripharmaspecialty.com\/es\/#organization","name":"Atenci\u00f3n especializada de Ameripharma","url":"https:\/\/ameripharmaspecialty.com\/es\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/ameripharmaspecialty.com\/es\/#\/schema\/logo\/image\/","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","width":400,"height":400,"caption":"Ameripharma Specialty Care"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ameripharma\/"]},{"@type":"Person","@id":"https:\/\/ameripharmaspecialty.com\/es\/#\/schema\/person\/f70b3467e035aab4ae14bdadd64c5c01","name":"Dra. Saba Rassouli, Farmac\u00e9utica","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/a5087340dca0d3046e3ff88f5dfa11d515d21ea9e06e6aec23e56d7fddfee7ce?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a5087340dca0d3046e3ff88f5dfa11d515d21ea9e06e6aec23e56d7fddfee7ce?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a5087340dca0d3046e3ff88f5dfa11d515d21ea9e06e6aec23e56d7fddfee7ce?s=96&d=mm&r=g","caption":"Dr. Saba Rassouli, PharmD"},"description":"La Dra. Saba Rassouli, doctora en farmacia, naci\u00f3 y creci\u00f3 en Ir\u00e1n. Obtuvo su t\u00edtulo en farmacia en la Universidad Marshall B. Ketchum en 2022, donde se gradu\u00f3 con honores. Lo m\u00e1s gratificante de su trabajo es tener la oportunidad de atender a cada paciente como si fuera de su familia y escuchar lo contentos y satisfechos que est\u00e1n con los servicios de AmeriPharma. En su tiempo libre, le gusta pasear, leer y probar diferentes restaurantes y comidas.","url":"https:\/\/ameripharmaspecialty.com\/es\/author\/saba-rassouli\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/doctor-skin-exam.jpg",1280,854,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/doctor-skin-exam-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/doctor-skin-exam-300x200.jpg",300,200,true],"medium_large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/doctor-skin-exam-768x512.jpg",768,512,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/doctor-skin-exam-1024x683.jpg",1024,683,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/doctor-skin-exam.jpg",1280,854,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/doctor-skin-exam.jpg",1280,854,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/doctor-skin-exam-18x12.jpg",18,12,true],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/doctor-skin-exam-600x400.jpg",600,400,true],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/doctor-skin-exam-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/doctor-skin-exam-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/doctor-skin-exam-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/doctor-skin-exam-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/doctor-skin-exam-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/doctor-skin-exam-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/doctor-skin-exam-960x641.jpg",960,641,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/doctor-skin-exam.jpg",1280,854,false]},"uagb_author_info":{"display_name":"Dr. Saba Rassouli, PharmD","author_link":"https:\/\/ameripharmaspecialty.com\/es\/author\/saba-rassouli\/"},"uagb_comment_info":0,"uagb_excerpt":"Odomzo (sonidegib) is a medication\u00a0 that treats basal cell carcinoma (BCC), which is a type of skin cancer that develops in the uppermost layer of the skin. It is a common form of skin cancer that affects around 3.6 million Americans each year.\u00a0","rttpg_featured_image_url":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/doctor-skin-exam.jpg",1280,854,false],"landscape":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/doctor-skin-exam.jpg",1280,854,false],"portraits":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/doctor-skin-exam.jpg",1280,854,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/doctor-skin-exam-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/doctor-skin-exam-300x200.jpg",300,200,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/doctor-skin-exam-1024x683.jpg",1024,683,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/doctor-skin-exam.jpg",1280,854,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/doctor-skin-exam.jpg",1280,854,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/doctor-skin-exam-18x12.jpg",18,12,true],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/doctor-skin-exam-600x400.jpg",600,400,true],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/doctor-skin-exam-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/doctor-skin-exam-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/doctor-skin-exam-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/doctor-skin-exam-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/doctor-skin-exam-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/doctor-skin-exam-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/doctor-skin-exam-960x641.jpg",960,641,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/doctor-skin-exam.jpg",1280,854,false]},"rttpg_author":{"display_name":"Dr. Saba Rassouli, PharmD","author_link":"https:\/\/ameripharmaspecialty.com\/es\/author\/saba-rassouli\/"},"rttpg_comment":0,"rttpg_category":"<a href=\"https:\/\/ameripharmaspecialty.com\/es\/category\/cancer\/\" rel=\"category tag\">Cancer<\/a>","rttpg_excerpt":"Odomzo (sonidegib) is a medication\u00a0 that treats basal cell carcinoma (BCC), which is a type of skin cancer that develops in the uppermost layer of the skin. It is a common form of skin cancer that affects around 3.6 million Americans each year.\u00a0","_links":{"self":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts\/27635","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/users\/13"}],"replies":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/comments?post=27635"}],"version-history":[{"count":0,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts\/27635\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/media\/27636"}],"wp:attachment":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/media?parent=27635"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/categories?post=27635"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/tags?post=27635"}],"curies":[{"name":"gracias","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}